Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006; 7(5): 281–90
Cunliffe WJ. Acne and unemployment [letter]. Br J Dermatol 1986; 115: 386
Gollnick MD, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49: S1–38
Till AE, Goulden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000; 142: 885–92
Leyden JJ. Antibiotic resistance in the topical treatment of acne vulgaris. Cutis 2004 Jun; 73(6 Suppl.): 6–10
Griffiths CEM. Nicotinamide 4% gel for the treatment of inflammatory acne. J Dermatolog Treat 1995; 6Suppl. 1: S8–10
Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother 2005 Mar; 6(3): 409–18
Dreno B, Bettoli V, Ochsendorf F. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004; 14(6): 391–9
Shaw JC, White LE. Persistent acne in adult women. Arch Dermatol 2001; 137: 1252–3
DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent Clin North Am 2002; 46(4): 653–4
Honein MA, Lindstrom JA, Kweder SL. Can we ensure the safe use of known human teratogens?: the iPLEDGE™ test case. Drug Saf 2007; 30(1): 5–15
Committee for Proprietary Medicinal Products (CPMP). Summary information on a referral opinion following an arbitration pursuant to article 30 of directive 2001/83/ED, for Roaccutane and associated names. London: European Agency for the Evaluation of Medicinal Products, 2003
Goulden V, Clark SM, McGeown C, et al. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997 Jul; 137(1): 106–8
Zane LT. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006 May; 142(5): 638–40
iPledge™: committed to pregnancy prevention [online]. Available from URL: https://www.ipledgeprogram.com [Accessed 2007 Mar 13]
Huber J, Foidart JM, Wuttke W, et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone. Eur J Contracept Reprod Health Care 2000; 5: 25–34
Shaw JC. Hormonal therapy in dermatology. Dermatol Clin 2001; 19: 169–78
Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984; 111: 209–14
Cusan L, Dupont A, Belanger A, et al. Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 1990; 23: 462–9
Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. Br J Dermatol 1991; 125: 256–9
Atzori L, Brundu MA, Orru A. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol 1999; 12: 119–22
Rights and permissions
About this article
Cite this article
Consider acne severity and patient preferences when treating post-adolescent acne in women. Drugs Ther. Perspect 23, 12–15 (2007). https://doi.org/10.2165/00042310-200723060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200723060-00004